Toshikazu Yamanishi leads at the start of the men’s 20-kilometer race walk on Friday at the World Athletics Championships in Eugene, Ore.
13:52 JST, July 16, 2022
EUGENE, Ore. — Toshikazu Yamanishi won the men’s 20-kilometer race walk on the opening day of the World Athletics Championships on Friday in Eugene, Ore., making him the first Japanese in history to repeat as a world or Olympic champion in the sport.
Yamanishi clocked 1 hour 19 minutes 7 seconds to add to the gold he won three years ago in Doha and finish seven seconds ahead of Olympic silver medalist and compatriot Koki Ikeda — giving Japan its first-ever 1-2 finish at the World Athletics Championships.
“I’m really proud of myself,” said Yamanishi, who was coming off a disappointing third-place finish at the Tokyo Olympics.
Yamanishi and Ikeda were among the lead pack from the start and broke away from their closest competitors before the 18-kilometer mark. The 26-year-old Yamanishi pulled away in the final kilometer to take the gold.
“I wanted to dictate how the race evolved,” Yamanishi said.
Top Articles in Sports
-
Milano Cortina 2026: Figure Skaters Riku Miura, Ryuichi Kihara Pair Win Gold; Dramatic Comeback from 5th Place in SP
-
Milano Cortina 2026: Japanese Gold Medalist Figure Skater Miura Says When Kihara Retires ‘I Retire Too’
-
Milano Cortina 2026: Riku Miura, Ryuichi Kihara Clinch Japan’s 1st Gold in Pairs Figure Skating, Rebounding from Disappointing Short Program
-
Milano Cortina 2026: Kokomo Murase Comes Out on Top After Overcoming Obstacles, Aiming for Greater Heights in Competition
-
Milano Cortina 2026: Japan’s Mari Fukada Wins Gold in Women’s Snowboard Slopestyle; Japan’s Kokomo Murase in Bronze
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Videos Plagiarized, Reposted with False Subtitles Claiming ‘Ryukyu Belongs to China’; Anti-China False Information Also Posted in Japan
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

